Packard C - Search Results

1

Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study.

Caslake MJ, Miles EA, Kofler BM, Lietz G, Curtis P, Armah CK, Kimber AC, Grew JP, Farrell L, Stannard J, Napper FL, Sala-Vila A, West AL, Mathers JC, Packard C, Williams CM, Calder PC, Minihane AM. Caslake MJ, et al. Among authors: packard c. Am J Clin Nutr. 2008 Sep;88(3):618-29. doi: 10.1093/ajcn/88.3.618. Am J Clin Nutr. 2008. PMID: 18779276 Free article.

2

Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease.

Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ. Deighan CJ, et al. J Am Soc Nephrol. 2001 Feb;12(2):341-348. doi: 10.1681/ASN.V122341. J Am Soc Nephrol. 2001. PMID: 11158224 Clinical Trial.

3

Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.

Gaffney D, Forster L, Caslake MJ, Bedford D, Stewart JP, Stewart G, Wieringa G, Dominiczak M, Miller JP, Packard CJ. Gaffney D, et al. Atherosclerosis. 2002 May;162(1):33-43. doi: 10.1016/s0021-9150(01)00679-7. Atherosclerosis. 2002. PMID: 11947895

4

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.

Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N; West of Scotland Coronary Prevention Study. Freeman DJ, et al. Diabetes. 2002 May;51(5):1596-600. doi: 10.2337/diabetes.51.5.1596. Diabetes. 2002. PMID: 11978661

5

UK Food Standards Agency cis-monounsaturated fatty acid workshop report.

Sanderson P, Gill JM, Packard CJ, Sanders TA, Vessby B, Williams CM. Sanderson P, et al. Br J Nutr. 2002 Jul;88(1):99-104. doi: 10.1079/BJNBJN2002595. Br J Nutr. 2002. PMID: 12117433 Review.

6

Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.

Forster LF, Stewart G, Bedford D, Stewart JP, Rogers E, Shepherd J, Packard CJ, Caslake MJ. Forster LF, et al. Atherosclerosis. 2002 Sep;164(1):129-45. doi: 10.1016/s0021-9150(02)00052-7. Atherosclerosis. 2002. PMID: 12119202 Clinical Trial.

7

Regulation of small dense LDL concentration in Korean and Scottish men and women.

Cho HK, Shin G, Ryu SK, Jang Y, Day SP, Stewart G, Packard CJ, Shepherd J, Caslake MJ. Cho HK, et al. Atherosclerosis. 2002 Sep;164(1):187-93. doi: 10.1016/s0021-9150(02)00058-8. Atherosclerosis. 2002. PMID: 12119209

8

New dimension of statin action on ApoB atherogenicity.

Chapman MJ, Caslake M, Packard C, McTaggart F. Chapman MJ, et al. Among authors: packard c. Clin Cardiol. 2003 Jan;26(1 Suppl 1):I7-10. doi: 10.1002/clc.4960261304. Clin Cardiol. 2003. PMID: 12539816 Free PMC article. Review.

9

Effects of dietary monounsaturated fatty acids on lipoprotein concentrations, compositions, and subfraction distributions and on VLDL apolipoprotein B kinetics: dose-dependent effects on LDL.

Gill JM, Brown JC, Caslake MJ, Wright DM, Cooney J, Bedford D, Hughes DA, Stanley JC, Packard CJ. Gill JM, et al. Among authors: packard cj. Am J Clin Nutr. 2003 Jul;78(1):47-56. doi: 10.1093/ajcn/78.1.47. Am J Clin Nutr. 2003. PMID: 12816770 Clinical Trial.

10

Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease.

Caslake MJ, Packard CJ. Caslake MJ, et al. Curr Opin Lipidol. 2003 Aug;14(4):347-52. doi: 10.1097/00041433-200308000-00002. Curr Opin Lipidol. 2003. PMID: 12865731 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

501 results

Search Page